Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
A number of other countries have implemented changes in law that significantly reduce the extent of criminalization of marijuana use. Only in Australia and the Netherlands have there been any changes on the criminalization of the supply side and in neither of those countries is it legal to both produce and sell the drug. The relaxations so far, with the exception of the Netherlands, have not been very great i.e. have not much changed the legal risks faced by a user of marijuana. Thus it is perhaps not surprising that the changes in prevalence of use have not been substantial. This paper provides a brief review of the changes that have been tried outside the US. The emphasis is on the nature of the changes and how they have been implemented rather than on outcomes.
D. Thanki, J. Matias, P. Griffiths, A. Noor, D. Olszewski, R. Simon, J. Vicente
14 နိုဝင်ဘာလ 2012
This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported data regarding frequency of cannabis use from large, probabilistic, nationally representative samples of general population surveys from 20 countries, representing more than 83 % of the population of EU and Norway, were collected through two rounds of ad hoc data collection in 2004 and 2007 and through a routine, standard data collection instrument since 2010.
Three United Nations Conventions provide the international legal framework on drug control, instructing countries to limit drug supply and use to medical and scientific purposes. Yet, debate continues on the decriminalisation, or even legalisation, of drugs, particularly cannabis. Models under development for the legal supply of cannabis are described in this analysis, as well as some of the questions they raise.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
This is a guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world, who are witnessing the question change from, 'Should we maintain cannabis prohibition?' to 'How will legal regulation work in practice?
La politique vis-à-vis du cannabis est en rapide évolution. Ainsi, les citoyens de l'Alaska et de l'Oregon, comme ceux de Washington DC, la capitale des Etats-Unis, viennent à leur tour de légaliser la possession de cannabis et, pour les deux premiers, d'autoriser un marché régulé pour cette substance. Des expériences de ce type sont depuis peu en cours ailleurs aux Etats-Unis et dans le monde. Quelles leçons peut-on déjà en tirer? Addiction Suisse propose une vue d'ensemble des développements les plus récents dans les Amériques, en Europe et en Suisse.
Während die Reform der Cannabispolitik in Amerika Fahrt aufnimmt, scheint Europa hinterherzuhinken. Genauer gesagt, die europäischen Staaten auf nationaler Regierungsebene, wo die Leugnung der Veränderungen in der politischen Landschaft und die Trägheit bei der Reaktion auf Forderungen nach einem Wandel noch immer vorherrschen. Auf lokaler Ebene hingegen führt die Ernüchterung hinsichtlich der aktuellen Cannabispolitik zur Entstehung neuer Ideen. In verschiedenen europäischen Ländern prüfen lokale und regionale Behörden eine Regulierung, entweder unter dem Druck von Basisbewegungen – vor allem den Cannabis Social Clubs (CSC) – oder wegen der Verstrickung krimineller Gruppen und zur Aufrechterhaltung der öffentlichen Ordnung.
France offers the most recent sign of changing attitudes. While consumption and production of pot for personal use are not criminal offenses in France, growing and selling for other than personal use is illegal. So 150 to 200 “clubs” of growers operating quietly, and their umbrella association called Cannabis Social Clubs, have decided to come out of the dark to lobby openly for legalization.
Some 20 years ago, a Spanish official in favor of lifting the ban on drugs such as marijuana mentioned at a UN meeting that there "might be a more humane option" in the fight against trafficking. She was immediately taken aside by a senior diplomat, who told her in no uncertain terms: "Don't say things like that round here, not even in the washroom." Today, the same official says that internal documents are now circulating within the UN that openly admit to the failure of prohibition.
Cannabis is the world’s most widely used illicit drug. But for how much longer? In a short space of time we have moved from absolute global prohibition of the drug, with the emergence of legalised and regulated production and retail not in just one nation (Uruguay) but also, surprisingly, in two US states (Colorado and Washington). Do these and other new permissive models in Spain and Belgium, for example, point to a tipping point in the debate? Could cannabis step out of the shadows and join the ranks of alcohol and tobacco, the world’s most popular legal and regulated drugs?
No fewer than six randomised controlled trials – in Switzerland, the Netherlands, Germany, Spain, Canada, and England – concluded that heroin assisted treatment is more effective than conventional treatments in a subgroup of heroin users.